Literature DB >> 23526079

CXCR4-mediated Stat3 activation is essential for CXCL12-induced cell invasion in bladder cancer.

Hai-bo Shen1, Zheng-qin Gu, Kang Jian, Juan Qi.   

Abstract

CXCL12/CXCR4 signaling plays important roles in tumor cell metastasis in many types of cancers, and CXCR4 is the key regulator of cell motility in bladder cancer. Emerging evidence suggests that transcription-3 (Stat3) activation is associated with bladder cancer cell growth and survival, while the relationship between CXCL12/CXCR4 signal and Stat3 activation remains unclear. In this study, expression analysis of bladder cancer and adjacent normal tissues showed that higher CXCR4 expression was associated with Stat3 phosphorylation. CXCR4 knockdown in bladder cancer T24 cells impaired CXCL12-induced cell invasion and Stat3 activation. Furthermore, blocking Stat3 activity with the chemical inhibitor Stattic inhibited CXCL12-triggered Stat3 phosphorylation and cell invasion in T24 cells, suggesting that Stat3 activation is required for CXCL12 function in the mobility of bladder cancer. Taken together, CXCR4 is necessary for CXCL12 signal transduction in bladder cancer, and CXCL12/CXCR4 promotes invasion of bladder cancer cells through activation of Stat3 transcriptional activity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23526079     DOI: 10.1007/s13277-013-0725-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  35 in total

1.  Stat3 activation in urothelial stem cells leads to direct progression to invasive bladder cancer.

Authors:  Philip Levy Ho; Erica Julianne Lay; Weiguo Jian; Diana Parra; Keith Syson Chan
Journal:  Cancer Res       Date:  2012-04-24       Impact factor: 12.701

Review 2.  Homeostatic chemokine receptors and organ-specific metastasis.

Authors:  Albert Zlotnik; Amanda M Burkhardt; Bernhard Homey
Journal:  Nat Rev Immunol       Date:  2011-08-25       Impact factor: 53.106

Review 3.  Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer.

Authors:  M Z Dewan; S Ahmed; Y Iwasaki; K Ohba; M Toi; N Yamamoto
Journal:  Biomed Pharmacother       Date:  2006-06-28       Impact factor: 6.529

4.  Glycosaminoglycans and syndecan-4 are involved in SDF-1/CXCL12-mediated invasion of human epitheloid carcinoma HeLa cells.

Authors:  Severine Brule; Véronique Friand; Angela Sutton; Françoise Baleux; Liliane Gattegno; Nathalie Charnaux
Journal:  Biochim Biophys Acta       Date:  2009-08-17

5.  Rapid activation of Stat3 and ERK1/2 by nicotine modulates cell proliferation in human bladder cancer cells.

Authors:  Rong-Jane Chen; Yuan-Soon Ho; How-Ran Guo; Ying-Jan Wang
Journal:  Toxicol Sci       Date:  2008-04-30       Impact factor: 4.849

6.  CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion.

Authors:  Shailesh Singh; Udai P Singh; William E Grizzle; James W Lillard
Journal:  Lab Invest       Date:  2004-12       Impact factor: 5.662

Review 7.  STATs in cancer inflammation and immunity: a leading role for STAT3.

Authors:  Hua Yu; Drew Pardoll; Richard Jove
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

Review 8.  Bladder cancer.

Authors:  Donald S Kaufman; William U Shipley; Adam S Feldman
Journal:  Lancet       Date:  2009-06-10       Impact factor: 79.321

Review 9.  Is there standard chemotherapy for metastatic bladder cancer? Quality of life and medical resources utilization based on largest to date randomized trial.

Authors:  Jan Lehmann; Margitta Retz; Michael Stöckle
Journal:  Crit Rev Oncol Hematol       Date:  2003-08       Impact factor: 6.312

10.  CXCL12 and [N33A]CXCL12 in 5637 and HeLa cells: regulating HER1 phosphorylation via calmodulin/calcineurin.

Authors:  Antonella Rigo; Michele Gottardi; Ernesto Damiani; Massimiliano Bonifacio; Isacco Ferrarini; Pierluigi Mauri; Fabrizio Vinante
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

View more
  11 in total

1.  Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms.

Authors:  Carolyn C Tu; Kathleen L Arnolds; Christine M O'Connor; Juliet V Spencer
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

Review 2.  [How do metastases of urological tumors develop?].

Authors:  M Rose; R Knüchel
Journal:  Urologe A       Date:  2014-06       Impact factor: 0.639

Review 3.  Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.

Authors:  Alireza Nazari; Hossein Khorramdelazad; Gholamhossein Hassanshahi
Journal:  Int J Clin Oncol       Date:  2017-10-11       Impact factor: 3.402

Review 4.  Role of STAT3 pathway in genitourinary tumors.

Authors:  Matteo Santoni; Alessandro Conti; Francesco Piva; Francesco Massari; Chiara Ciccarese; Luciano Burattini; Liang Cheng; Antonio Lopez-Beltran; Marina Scarpelli; Daniele Santini; Giampaolo Tortora; Stefano Cascinu; Rodolfo Montironi
Journal:  Future Sci OA       Date:  2015-11-01

5.  AID modulates carcinogenesis network via DNA demethylation in bladder urothelial cell carcinoma.

Authors:  Haoyong Li; Qi Li; Zhe Ma; Zhiyan Zhou; Jinfeng Fan; Yingxia Jin; Yaoxi Wu; Fan Cheng; Peiyu Liang
Journal:  Cell Death Dis       Date:  2019-03-15       Impact factor: 8.469

6.  A zebrafish embryo screen utilizing gastrulation identifies the HTR2C inhibitor pizotifen as a suppressor of EMT-mediated metastasis.

Authors:  Joji Nakayama; Lora Tan; Yan Li; Boon Cher Goh; Shu Wang; Hideki Makinoshima; Zhiyuan Gong
Journal:  Elife       Date:  2021-12-17       Impact factor: 8.140

7.  The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide.

Authors:  Hila Shaim; Zeev Estrov; David Harris; Mayra Hernandez Sanabria; Zhiming Liu; Peter Ruvolo; Phillip A Thompson; Alessandra Ferrajoli; May Daher; Jan Burger; Muharrem Muftuoglu; Nobuhiko Imahashi; Li Li; Enli Liu; Abdullah Saleh Alsuliman; Rafet Basar; Lucila Nassif Kerbauy; Catherine Sobieski; Elif Gokdemir; Kayo Kondo; William Wierda; Michael Keating; Elizabeth J Shpall; Katayoun Rezvani
Journal:  Front Immunol       Date:  2018-01-15       Impact factor: 7.561

Review 8.  Inflammatory microenvironment in the initiation and progression of bladder cancer.

Authors:  Xinbing Sui; Liming Lei; Liuxi Chen; Tian Xie; Xue Li
Journal:  Oncotarget       Date:  2017-10-06

9.  CXCL12 suppresses cisplatin-induced apoptosis through activation of JAK2/STAT3 signaling in human non-small-cell lung cancer cells.

Authors:  Meng Wang; Tie Lin; Yicun Wang; Song Gao; Zhaoyang Yang; Xuan Hong; Gongyan Chen
Journal:  Onco Targets Ther       Date:  2017-06-29       Impact factor: 4.147

10.  STAT3/5 Inhibitors Suppress Proliferation in Bladder Cancer and Enhance Oncolytic Adenovirus Therapy.

Authors:  Sruthi V Hindupur; Sebastian C Schmid; Jana Annika Koch; Ahmed Youssef; Eva-Maria Baur; Dongbiao Wang; Thomas Horn; Julia Slotta-Huspenina; Juergen E Gschwend; Per Sonne Holm; Roman Nawroth
Journal:  Int J Mol Sci       Date:  2020-02-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.